文献速递肾小球疾病

IgA肾病快速进展者循环细胞中蛋白酶体向免疫蛋白酶体转换增加且与CD46表达缺陷相关

The switch from proteasome to immunoproteasome is increased in circulating cells of patients with fast progressive immunoglobulin A nephropathy and associated with defective CD46 expression.
PubMed 文献 · Nephrol Dial Transplant · 2021-01-01

该研究纳入157例经VALIGA研究入组的IgA肾病患者,随访中位6.4年,分析循环细胞中蛋白酶体向免疫蛋白酶体转换与eGFR下降速率的关系。发现LMP7/β5转换与eGFR下降速率显著相关(P=0.026),快速进展者LMP7/β5 mRNA升高(P=0.04)且CD46 mRNA降低(P<0.01),高LMP7/β5联合低CD46对进展有较高预测价值。

要点

  • IgA肾病患者循环细胞存在LMP7/β5和LMP2/β1免疫蛋白酶体转换上调。
  • LMP7/β5转换与eGFR下降速率相关,与活检时eGFR无关。
  • 高LMP7/β5联合低CD46 mRNA对肾病进展有较高预测价值。

核心结论

  • IgA肾病患者循环细胞中蛋白酶体向免疫蛋白酶体转换增加,LMP7/β5转换与更快的肾功能下降相关,并与CD46表达缺陷相关。

研究设计与样本

  • 研究纳入157例经跨国VALIGA研究入组的IgA肾病患者,随访中位6.4年,计算eGFR下降斜率。
  • 检测循环细胞中免疫蛋白酶体亚基mRNA、PSMB8/PSMB9 locus rs9357155、TLR及CD46 mRNA表达。

主要发现

  • 检测到LMP7/β5和LMP2/β1转换上调。
  • rs9357155未见遗传效应。
  • TLR4和TLR2 mRNA与免疫蛋白酶体转换显著相关,尤其TLR4与LMP7/β5(P<0.0001)。
  • LMP7/β5转换与eGFR下降速率显著相关(P=0.026),但与活检时eGFR无关。
  • 快速进展者(eGFR下降>第75百分位,即-1.91 mL/min/1.73 m2/年)LMP7/β5 mRNA显著升高(P=0.04),CD46 mRNA显著降低(P<0.01)。

关键数值与推荐

  • 快速进展定义为eGFR下降>第75百分位,即-1.91 mL/min/1.73 m2/年。
  • 多因素logistic回归模型按肾病进展不同水平分类,显示高LMP7/β5联合低CD46表达具有高预测价值。

临床怎么用

  • 循环细胞LMP7/β5和CD46 mRNA表达可能作为IgA肾病进展风险的生物标志物组合。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The proteasome to immunoproteasome (iPS) switch consists of β1, β2 and β5 subunit replacement by low molecular weight protein 2 (LMP2), LMP7 and multicatalytic endopeptidase-like complex-1 (MECL1) subunits, resulting in a more efficient peptide preparation for major histocompatibility complex 1 (MHC-I) presentation. It is activated by toll-like receptor (TLR) agonists and interferons and may also be influenced by genetic variation. In a previous study we found an iPS upregulation in peripheral cells of patients with immunoglobulin A nephropathy (IgAN). We aimed to investigate in 157 IgAN patients enrolled through the multinational Validation Study of the Oxford Classification of IgAN (VALIGA) study the relationships between iPS switch and estimated glomerular filtration rate (eGFR) modifications from renal biopsy to sampling. Patients had a previous long follow-up (6.4 years in median) that allowed an accurate calculation of their slope of renal function decline. We also evaluated the effects of the PSMB8/PSMB9 locus (rs9357155) associated with IgAN in genome-wide association studies and the expression of messenger RNAs (mRNAs) encoding for TLRs and CD46, a C3 convertase inhibitor, acting also on T-regulatory cell promotion, found to have reduced expression in progressive IgAN. We detected an upregulation of LMP7/β5 and LMP2/β1 switches. We observed no genetic effect of rs9357155. TLR4 and TLR2 mRNAs were found to be significantly associated with iPS switches, particularly TLR4 and LMP7/β5 (P < 0.0001). The LMP7/β5 switch was significantly associated with the rate of eGFR loss (P = 0.026), but not with eGFR at biopsy. Fast progressors (defined as the loss of eGFR >75th centile, i.e. -1.91 mL/min/1.73 m2/year) were characterized by significantly elevated LMP7/β5 mRNA (P = 0.04) and low CD46 mRNA expression (P < 0.01). A multivariate logistic regression model, categorizing patients by different levels of kidney disease progression, showed a high prediction value for the combination of high LMP7/β5 and low CD46 expression.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Peruzzi L, Coppo R, Cocchi E, et al. The switch from proteasome to immunoproteasome is increased in circulating cells of patients with fast progressive immunoglobulin A nephropathy and associated with defective CD46 expression. Nephrol Dial Transplant. 2021. PMID: 32582935. doi:10.1093/ndt/gfaa092

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。